FDA調查可能與Takeda的酶替代療法相關的兒童死亡事件
FDA investigates child death potentially related to Takeda's enzyme replacement therapy
#FDA investigates#blood disorder#Takeda enzyme#potentially related#investigates child
生物技术与制药领域的最新动态
FDA investigates child death potentially related to Takeda's enzyme replacement therapy
Novo, Lilly begin to sell obesity medications directly to employers
Lilly becomes first $1 trillion pharma company
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move
Under RFK Jr., vaccine use slides while suspicion rises
Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy in China - Endpoints News